3 completed, 3 recruiting. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Recruiting 3 |
| Phase 2 | 1 | Completed 1 |
Follow Gastrointestinal Tumor: new trials by email Literature Review of Gastrointestinal Tumor trials Research Report on Gastrointestinal Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors SI-B036 - Gastrointestinal Tumor, Solid Tumor | Phase 1 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 10 | 2026-07-30 | 2026-09-04 |
| A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors BL-M09D1 - Gastrointestinal Tumor, Solid Tumor | Phase 1 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 45 | 2025-05-15 | 2025-05-31 |
| A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor BL-B01D1 - Gastrointestinal Tumor | Phase 1 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 96 | 2022-02-14 | 2026-08-27 |
| Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany), tislelizumab (BeiGene, China) combined with PD-1 inhibitor - Gastrointestinal Tumor | Phase 1 / Phase 2 | Completed | Pengyuan Liu | 18 | 2020-06-01 | 2023-09-05 |
| A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas alemtuzumab, fludarabine, sirolimus - Ewing Sarcoma, Gastrointestinal Tumor | Phase 1 | Completed | St. Jude Children's Research Hospital | 23 | 2012-08-20 | 2026-02-06 |
| Phase I Trial of Combination of FOLFIRI and SOM 230 SOM230C LAR, FOLFIRI Infusion - Gastrointestinal Tumor | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 16 | 2011-09-01 | 2015-12-24 |
Digestive System Neoplasms (6) · Adenocarcinoma, Clear Cell (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Hyperthermia (1) · Lymphoma (1) · Melanoma (1) · Neoplasm Metastasis (1) · Neoplasms, Germ Cell and Embryonal (1) · Neuroblastoma (1) · Pancreatic Neoplasms (1) · Rhabdoid Tumor (1) · Rhabdomyosarcoma (1)
Digestive System Diseases (6) · Neoplasms (6) · Neoplasms by Site (6) · Pathological Conditions, Signs and Symptoms (2) · Adenocarcinoma (1) · Body Temperature Changes (1) · Carcinoma (1) · Colonic Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Esophageal Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1)
Alemtuzumab (1) · Busulfan (1) · Fluorouracil (1) · Immune Checkpoint Inhibitors (1) · Irinotecan (1) · Leucovorin (1) · Melphalan (1) · Sirolimus (1) · Stem Cell Transplantation (1) · fludarabine (1) · spartalizumab (1) · tislelizumab (1)
Sichuan Baili Pharmaceutical Co., Ltd. (3) · H. Lee Moffitt Cancer Center and Research Institute (1) · Pengyuan Liu (1) · St. Jude Children's Research Hospital (1)
China (4) · United States (2)
Brando Triplett, MD (1) · Jun Chen (1) · Lin Shen, PHD (1) · Richard Kim, M.D. (1)